Akathisia and Newer Second‐Generation Antipsychotic Drugs: A Review of Current Evidence
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Akathisia and Newer Second‐Generation Antipsychotic Drugs: A Review of Current Evidence
Authors
Keywords
-
Journal
PHARMACOTHERAPY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-04-28
DOI
10.1002/phar.2404
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia
- (2018) Andy Forbes et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia
- (2018) Henry A. Nasrallah et al. CNS SPECTRUMS
- Maintenance therapy with second generation antipsychotics for bipolar disorder – A systematic review and meta-analysis
- (2017) Leif Lindström et al. JOURNAL OF AFFECTIVE DISORDERS
- Activating and Sedating Adverse Effects of Second-Generation Antipsychotics in the Treatment of Schizophrenia and Major Depressive Disorder
- (2017) Leslie Citrome JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
- (2017) György Németh et al. LANCET
- An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression
- (2016) Suresh Durgam et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Randomized Trial of Iloperidone for Prevention of Relapse in Schizophrenia: The REPRIEVE Study
- (2016) Peter J. Weiden et al. CNS DRUGS
- Asenapine for the treatment of adults with an acute exacerbation of schizophrenia: results from a randomized, double-blind, fixed-dose, placebo-controlled trial with olanzapine as an active control
- (2016) Ronald Landbloom et al. CNS SPECTRUMS
- Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study
- (2016) Christoph U. Correll et al. CNS SPECTRUMS
- Cariprazine in the treatment of schizophrenia
- (2016) Suresh Durgam et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Asenapine: Efficacy and safety of 5 and 10 mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder
- (2016) Ronald L. Landbloom et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants
- (2016) Suresh Durgam et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effect of Aripiprazole Lauroxil on Metabolic and Endocrine Profiles and Related Safety Considerations Among Patients With Acute Schizophrenia
- (2016) Henry A. Nasrallah et al. JOURNAL OF CLINICAL PSYCHIATRY
- Lurasidone Dose Escalation in Early Nonresponding Patients With Schizophrenia
- (2016) Antony Loebel et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial
- (2015) Christoph U. Correll et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cariprazine in the treatment of acute mania in bipolar I disorder: A double-blind, placebo-controlled, Phase III trial
- (2015) Gary S. Sachs et al. JOURNAL OF AFFECTIVE DISORDERS
- Cariprazine in Acute Exacerbation of Schizophrenia
- (2015) Suresh Durgam et al. JOURNAL OF CLINICAL PSYCHIATRY
- Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants
- (2015) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder
- (2015) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHIATRY
- A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia
- (2015) John M. Kane et al. SCHIZOPHRENIA RESEARCH
- Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study
- (2014) W. Wolfgang Fleischhacker et al. BRITISH JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Low- and High-Dose Cariprazine in Acute and Mixed Mania Associated With Bipolar I Disorder
- (2014) Joseph R. Calabrese et al. JOURNAL OF CLINICAL PSYCHIATRY
- An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: A phase II, randomized clinical trial
- (2014) Suresh Durgam et al. SCHIZOPHRENIA RESEARCH
- A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia
- (2014) Peter J. Weiden et al. SCHIZOPHRENIA RESEARCH
- Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
- (2013) Antony Loebel et al. AMERICAN JOURNAL OF PSYCHIATRY
- Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia
- (2013) Antony D. Loebel et al. CNS SPECTRUMS
- Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial
- (2013) Andrew J. Cutler et al. CNS SPECTRUMS
- Effectiveness of Lurasidone for Patients With Schizophrenia Following 6 Weeks of Acute Treatment With Lurasidone, Olanzapine, or Placebo
- (2013) Stephen M. Stahl et al. JOURNAL OF CLINICAL PSYCHIATRY
- Lurasidone for the treatment of acutely psychotic patients with schizophrenia: A 6-week, randomized, placebo-controlled study
- (2013) Henry A. Nasrallah et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Efficacy and safety of lurasidone 80mg/day and 160mg/day in the treatment of schizophrenia: A randomized, double-blind, placebo- and active-controlled trial
- (2013) Antony Loebel et al. SCHIZOPHRENIA RESEARCH
- Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study
- (2013) Antony Loebel et al. SCHIZOPHRENIA RESEARCH
- Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs
- (2012) Michael J. Peluso et al. BRITISH JOURNAL OF PSYCHIATRY
- Long-term safety and tolerability of lurasidone in schizophrenia
- (2012) Leslie Citrome et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia
- (2012) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Relationship of Akathisia with Treatment Emergent Suicidality among Patients with First-Episode Schizophrenia Treated with Haloperidol or Risperidone
- (2012) F. Seemüller et al. PHARMACOPSYCHIATRY
- Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study
- (2012) Masaaki Ogasa et al. PSYCHOPHARMACOLOGY
- Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study
- (2011) Herbert Y. Meltzer et al. AMERICAN JOURNAL OF PSYCHIATRY
- A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia
- (2011) W. Wolfgang Fleischhacker et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment
- (2011) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Adjunctive Oral Ziprasidone for Acute Treatment of Depression in Patients With Bipolar I Disorder
- (2011) Gary S. Sachs et al. JOURNAL OF CLINICAL PSYCHIATRY
- International Consensus Study of Antipsychotic Dosing
- (2010) David M. Gardner et al. AMERICAN JOURNAL OF PSYCHIATRY
- Acute antipsychotic-induced akathisia revisited
- (2010) Michael Poyurovsky BRITISH JOURNAL OF PSYCHIATRY
- Efficacy and safety of paliperidone palmitate in adult patients with acutely symptomatic schizophrenia: a randomized, double-blind, placebo-controlled, dose-response study
- (2010) Srihari Gopal et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Asenapine for long-term treatment of bipolar disorder: A double-blind 40-week extension study
- (2010) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Asenapine in the treatment of acute mania in bipolar I disorder: A randomized, double-blind, placebo-controlled trial
- (2010) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Ziprasidone Plus a Mood Stabilizer in Subjects With Bipolar I Disorder
- (2010) Charles L. Bowden et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Asenapine in a Placebo- and Haloperidol-Controlled Trial in Patients With Acute Exacerbation of Schizophrenia
- (2010) John M. Kane et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Second-Generation Antipsychotic Drugs and Extrapyramidal Side Effects: A Systematic Review and Meta-analysis of Head-to-Head Comparisons
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA BULLETIN
- Akathisia and second-generation antipsychotic drugs
- (2009) Rajeev Kumar et al. CURRENT OPINION IN PSYCHIATRY
- Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study
- (2009) Michelle Kramer et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Efficacy and Tolerability of Oral Paliperidone Extended-Release Tablets in the Treatment of Acute Schizophrenia
- (2009) Herbert Y. Meltzer et al. JOURNAL OF CLINICAL PSYCHIATRY
- Lurasidone in the Treatment of Acute Schizophrenia
- (2009) Mitsutaka Nakamura et al. JOURNAL OF CLINICAL PSYCHIATRY
- Akathisia: An Updated Review Focusing on Second-Generation Antipsychotics
- (2009) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Antipsychotic-Induced Extrapyramidal Side Effects in Bipolar Disorder and Schizophrenia
- (2009) Keming Gao et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A Double-Blind, Randomized Comparative Study of Aripiprazole and Olanzapine in Patients with Schizophrenia
- (2008) W. Wolfgang Fleischhacker et al. BIOLOGICAL PSYCHIATRY
- Four-Week, Double-Blind, Placebo- and Ziprasidone-Controlled Trial of Iloperidone in Patients With Acute Exacerbations of Schizophrenia
- (2008) Andrew J. Cutler et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Long-Term Efficacy and Safety of Iloperidone
- (2008) John M. Kane et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Safety Profile of Iloperidone
- (2008) Peter J. Weiden et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study
- (2008) E. Vieta et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
- (2008) Stefan Leucht et al. LANCET
- Safety and Tolerability of Oral Paliperidone Extended-Release Tablets in Elderly Patients With Schizophrenia: A Double-Blind, Placebo-Controlled Study With Six-Month Open-Label Extension
- (2007) Andreas Tzimos et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now